Basic info
Industry
biotechnology research
Sectors
Biotechnology
Prostate Cancer
Radiation Induced Lung Injury
humanized mAb
trauma-induced inflammatory lung injury
inflammatory disorders
Antibody-based therapies
eNamptorTM
Acute Respiratory Distress Syndrome (ARDS)
Medical
NAMPT (nicotinamide phosphoribosyltransferase)
ventilator induced lung injury
Date founded
2010
Funding rounds raised
Total raised
$17M
from 6 investors over 6 rounds
A
AQUALUNG THERAPEUTICS CORPORATION raised undisclosed on April 4, 2023
Investors: FLORIDA OPPORTUNITY FUND INC
A
AQUALUNG THERAPEUTICS CORPORATION raised $2.5M on January 18, 2022
Investors: JSR Life Sciences
A
AQUALUNG THERAPEUTICS CORPORATION raised $300K on September 22, 2020
Investors: National Institutes of Health
A
AQUALUNG THERAPEUTICS CORPORATION raised $2.3M on June 2, 2020
Investors: National Institutes of Health
A
AQUALUNG THERAPEUTICS CORPORATION raised $225K on August 20, 2019
Investors: National Institutes of Health
A
AQUALUNG THERAPEUTICS CORPORATION raised $17M on June 5, 2019
Investors: National Institute for Health Research (NIHR)